Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment-naïve”

973 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 973 results

Not applicableLooking for participantsNCT07474142
What this trial is testing

A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate Cancer

Who this might be right for
Newly Diagnosed, Treatment-naïve Prostate Cancer
Xijing Hospital 1,000
Large-scale testing (Phase 3)Active Not RecruitingNCT03528694
What this trial is testing

Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer

Who this might be right for
Non-muscle-invasive Bladder Cancer
AstraZeneca 1,018
Testing effectiveness (Phase 2)Study completedNCT01464827
What this trial is testing

ABT-450 With Ritonavir and ABT-267 and/or ABT-333 With and Without Ribavirin in Genotype 1 Hepatitis C Virus Infected Patients

Who this might be right for
Chronic Hepatitis CHepatitis C (HCV)Hepatitis C Genotype 1
AbbVie (prior sponsor, Abbott) 580
Testing effectiveness (Phase 2)UnknownNCT06406673
What this trial is testing

A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer

Who this might be right for
Extensive Small Cell Lung Cancer
Henan Cancer Hospital 70
Large-scale testing (Phase 3)Study completedNCT03067129
What this trial is testing

Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 129
Large-scale testing (Phase 3)Study completedNCT00570739
What this trial is testing

Effects of Metformin Hydrochloride (HCl) in Combination With Colesevelam HCl, Compared to Metformin HCl Alone, in Patients With Type 2 Diabetes Mellitus and the Effects of Colesevelam HCl on Lipids and Glucose on Pre-diabetic Patients.

Who this might be right for
Type 2 Diabetes MellitusHypercholesterolemiaPre-diabetes
Daiichi Sankyo 502
Testing effectiveness (Phase 2)Active Not RecruitingNCT05139602
What this trial is testing

Assess Disease Activity and Safety of Subcutaneous Lutikizumab (ABT-981) in Adult Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-Tumor Necrosis Factor (TNF) Therapy and Who Are Naïve to Biologic Therapy

Who this might be right for
Hidradenitis Suppurativa
AbbVie 210
Testing effectiveness (Phase 2)Study completedNCT04332744
What this trial is testing

Enzalutamide Plus Talazoparib for the Treatment of Hormone Sensitive Prostate Cancer (ZZ-First)

Who this might be right for
Metastatic Prostate Cancer
MedSIR 54
Not applicableNot Yet RecruitingNCT07542912
What this trial is testing

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

Who this might be right for
Complete Remission Rate， CRRProgression Free SurvivalOverall Survival+2 more
Sun Yat-sen University 30
Post-approval studies (Phase 4)Study completedNCT00351130
What this trial is testing

Effectiveness of a Valsartan Based vs an Amlodipine Based Treatment Strategy in naïve Patients With Stage 1 or Stage 2 Hypertension or in Patients Uncontrolled on Current Monotherapy

Who this might be right for
Hypertension
Novartis 79
Early research (Phase 1)Study completedNCT01525628
What this trial is testing

Drug Drug Interaction Study Between BI 201335 and BI 207127 in Chronic Hepatitis C Infected Patients

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 72
Post-approval studies (Phase 4)UnknownNCT02337322
What this trial is testing

Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir

Who this might be right for
Acquired Immune Deficiency Syndrome Virus
Juan A. Arnaiz 104
Early research (Phase 1)Study completedNCT03552536
What this trial is testing

MK-8583 Single Dose Study in Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants (MK-8583-002)

Who this might be right for
HIV-1 Infection
Merck Sharp & Dohme LLC 5
Large-scale testing (Phase 3)Study completedNCT02651194
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Renally Impaired Adults With Chronic Hepatitis C Virus Genotype 1 - 6 Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection
AbbVie 104
Not applicableLooking for participantsNCT06870630
What this trial is testing

Standard Versus Oesophago-gastric Junction Complex Myotomy for Treatment naïve Type 2 Achalasia Patients

Who this might be right for
Esophageal Diseases
Asian Institute of Gastroenterology, India 158
Testing effectiveness (Phase 2)Study completedNCT01072695
What this trial is testing

Efficacy and Safety Study of GS-9256 and GS-9190 Alone and in Combination With Ribavirin for 28 Days in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
HCV Infection
Gilead Sciences 46
Not applicableStudy completedNCT00700401
What this trial is testing

POTENTE Study: A Study of Early Virological Response in Naive Patients With Chronic Hepatitis C, Genotype 2 or 3, Treated With PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin).

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 262
Testing effectiveness (Phase 2)Study completedNCT01392716
What this trial is testing

MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma

Who this might be right for
Non-Hodgkin's Lymphoma
Hoffmann-La Roche 48
Early research (Phase 1)Study completedNCT01814826
What this trial is testing

Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older

Who this might be right for
Acute Myelogenous Leukemia
Millennium Pharmaceuticals, Inc. 64
Post-approval studies (Phase 4)Study completedNCT01591460
What this trial is testing

A Triple Combination Therapy Study of Boceprevir, Pegasys and Copegus in Previously Untreated Patients With Genotype 1 Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 165
Next Page